The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome #2: Consult with the Expert - Medical Management***Post-Assessment*** Survey

In order to receive credit for this activity, you must read the front matter, view the activity, complete the post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements.

There is no fee to participate in this activity.

Question Title

* 1. Where are you in your career?

IBD Specialist

General GI/GI surgeon

Trainee/Fellow

APP

PharmD

Other (please specify)

Question Title

* 2. What is your community of practice?

Academic

Community

Industry

Other (please specify)

Question Title

* 3. The GLP-2 analog teduglutide was shown in clinical studies to be associated with which of the following outcomes?

⬇️ Infection incidence

⬇️ Fluid requirement

⬆️ Caloric intake

⬇️ TPN complications

Question Title

* 4. A young adult patient with SBS is experiencing significant diarrhea (≥20 BM/day) despite tx with 8 mg/day loperamide. When the nurse discusses this with the doctor, a management strategy is formed, which includes which of the following?

⬆️ loperamide (12 mg/d)

⬇️ TPN daily volume

⬇️ # of days of TPN

⬆️ dietary fat

Question Title

* 5. A pediatric pt w/ SBS is being evaluated as an inpatient consult following a recent emergency resection, with 55 cm of small bowel remaining. Which of the following is an appropriate initial management strategy?

Altered diet & loperamide

NPO & PPIs

NPO & TPN

Antibiotics & codeine

Question Title

* 6. Which of the following is considered to be a potentially disease-modifying treatment for patients with SBS?

Clonidine

Loperamide

Somatropin

Teduglutide

Question Title

* 7. Following this #MNIBDWebinar, how confident are you in your ability to form a disease-modifying tx plan in pts w #ShortBowelSyndrome?

Very confident

Somewhat confident

Not very confident

Not at all confident

Question Title

* 8. Approximately how many patients with SBS do you currently see each week?

1-3

4-6

7-9

10+

I do not directly provide care for patients with SBS

Question Title

* 9. Upon completion of this activity, I am able to:

	Strongly agree	Agree	Disagree	Strongly disagree
Identify the role and complications associated with the use of TPN in pediatric patients with SBS	Identify the role and complications associated with the use of TPN in pediatric patients with SBS Strongly agree	Identify the role and complications associated with the use of TPN in pediatric patients with SBS Agree	Identify the role and complications associated with the use of TPN in pediatric patients with SBS Disagree	Identify the role and complications associated with the use of TPN in pediatric patients with SBS Strongly disagree
Interpret referral and treatment strategies to optimize a patient’s likelihood of achieving intestinal rehabilitation	Interpret referral and treatment strategies to optimize a patient’s likelihood of achieving intestinal rehabilitation Strongly agree	Interpret referral and treatment strategies to optimize a patient’s likelihood of achieving intestinal rehabilitation Agree	Interpret referral and treatment strategies to optimize a patient’s likelihood of achieving intestinal rehabilitation Disagree	Interpret referral and treatment strategies to optimize a patient’s likelihood of achieving intestinal rehabilitation Strongly disagree
Select pharmacologic options for treatment of pediatric patients with SBS	Select pharmacologic options for treatment of pediatric patients with SBS Strongly agree	Select pharmacologic options for treatment of pediatric patients with SBS Agree	Select pharmacologic options for treatment of pediatric patients with SBS Disagree	Select pharmacologic options for treatment of pediatric patients with SBS Strongly disagree

Question Title

* 10. Please indicate the extent of your agreement with the following statements:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
The faculty were effective in presenting the material	The faculty were effective in presenting the material Strongly agree	The faculty were effective in presenting the material Agree	The faculty were effective in presenting the material Neutral	The faculty were effective in presenting the material Disagree	The faculty were effective in presenting the material Strongly disagree
Information in this activity is relevant to my clinical practice	Information in this activity is relevant to my clinical practice Strongly agree	Information in this activity is relevant to my clinical practice Agree	Information in this activity is relevant to my clinical practice Neutral	Information in this activity is relevant to my clinical practice Disagree	Information in this activity is relevant to my clinical practice Strongly disagree
The activity increased my knowledge on this topic	The activity increased my knowledge on this topic Strongly agree	The activity increased my knowledge on this topic Agree	The activity increased my knowledge on this topic Neutral	The activity increased my knowledge on this topic Disagree	The activity increased my knowledge on this topic Strongly disagree
The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.)	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Strongly agree	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Agree	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Neutral	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Disagree	The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.) Strongly disagree
The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity)	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Strongly agree	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Agree	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Neutral	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Disagree	The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity) Strongly disagree

Question Title

* 11. Please rate your level of agreement by selecting the appropriate rating:
The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Was fair, balanced, objective, and free of commercial bias	Was fair, balanced, objective, and free of commercial bias Strongly agree	Was fair, balanced, objective, and free of commercial bias Agree	Was fair, balanced, objective, and free of commercial bias Neutral	Was fair, balanced, objective, and free of commercial bias Disagree	Was fair, balanced, objective, and free of commercial bias Strongly disagree

Question Title

* 12. Based upon your participation in this activity, do you intend to change your practice behavior?

I plan to implement changes in my practice based on the information presented

My current practice has been reinforced by the information presented

I need more information before I will change my practice

Not applicable to my scope of practice

Question Title

* 13. How confident are you that you will be able to make your intended changes?

Very confident

Somewhat confident

Unsure

Not confident

Question Title

* 14. Which of the following do you anticipate will be the primary barrier to implementing these changes? (check all that apply):

Formulary restrictions

Time constraints

System constraints

Patient adherence/compliance

Insurance/financial issues

Lack of interprofessional team support

Treatment related adverse events

None

Other (please specify)

Question Title

* 15. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 16. For purposes of certification, please complete the following information. Please note that we will not forward or sell your contact information.

First Name *

Last Name *

Degree/Credentials:

City

State/Province

ZIP/Postal Code *

Country

Email Address (required to receive credit) *

Question Title

* 17. I certify that I have participated in the continuing education activity entitled, "The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome #2: Consult with the Expert - Medical Management" and claim 0.5 AMA PRA Category 1 Credit^TM.

Yes

Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4-6 weeks to receive your certificate.

For information about the certification of this program, please contact Partners for Advancing Clinical Education (PACE) at contactus@partnersed.com.

The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome #2: Consult with the Expert - Medical Management***Post-Assessment***

Question Title

* 1. Where are you in your career?

Question Title

* 2. What is your community of practice?

Question Title

* 3. The GLP-2 analog teduglutide was shown in clinical studies to be associated with which of the following outcomes?

Question Title

* 4. A young adult patient with SBS is experiencing significant diarrhea (≥20 BM/day) despite tx with 8 mg/day loperamide. When the nurse discusses this with the doctor, a management strategy is formed, which includes which of the following?

Question Title

* 5. A pediatric pt w/ SBS is being evaluated as an inpatient consult following a recent emergency resection, with 55 cm of small bowel remaining. Which of the following is an appropriate initial management strategy?

Question Title

* 6. Which of the following is considered to be a potentially disease-modifying treatment for patients with SBS?

Question Title

* 7. Following this #MNIBDWebinar, how confident are you in your ability to form a disease-modifying tx plan in pts w #ShortBowelSyndrome?

Question Title

* 8. Approximately how many patients with SBS do you currently see each week?

Question Title

* 9. Upon completion of this activity, I am able to:

Question Title

* 10. Please indicate the extent of your agreement with the following statements:

Question Title

* 11. Please rate your level of agreement by selecting the appropriate rating:The content presented:

Question Title

* 12. Based upon your participation in this activity, do you intend to change your practice behavior?

Question Title

* 13. How confident are you that you will be able to make your intended changes?

Question Title

* 14. Which of the following do you anticipate will be the primary barrier to implementing these changes? (check all that apply):

Question Title

* 15. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 16. For purposes of certification, please complete the following information. *Please note that we will not forward or sell your contact information.*

Question Title

* 17. I certify that I have participated in the continuing education activity entitled, "The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome #2: Consult with the Expert - Medical Management" and claim 0.5 AMA PRA Category 1 CreditTM.

The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome
#2: Consult with the Expert - Medical Management
Post-Assessment

* 11. Please rate your level of agreement by selecting the appropriate rating:
The content presented:

* 16. For purposes of certification, please complete the following information. Please note that we will not forward or sell your contact information.

* 17. I certify that I have participated in the continuing education activity entitled, "The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome #2: Consult with the Expert - Medical Management" and claim 0.5 AMA PRA Category 1 Credit^TM.